Navigation Links
AccuVein AV300, First Portable Vein Illumination Device, Now Available on GSA Schedule

5-Year Contract Makes AccuVein's Device Now Available to Veteran and Military Hospitals

COLD SPRING HARBOR, N.Y., June 29 /PRNewswire/ -- AccuVein LLC today announced a five-year agreement with the U.S. General Services Administration (GSA). This agreement brings the AccuVein AV300, the world's first hand-held, non-contact vein illumination device, to GSA organizations including military and veteran hospitals.

The AccuVein AV300 helps healthcare professionals locate hard-to-find veins. IV starts, blood draws and blood donation (venipuncture) can be a source of patient anxiety and discomfort, and accessing veins in difficult patients can take up to 10 minutes and require multiple needle sticks. Venipuncture is the most common invasive medical procedure with an estimated 2.7 million procedures conducted every day in the United States alone. The AV300 can help reduce the need for multiple needle sticks, with the goal of improving patient care and the time to access veins.

"Adding the AccuVein AV300 on the GSA schedule brings a valuable device to these healthcare professionals at the front-line of patient care, enabling them to see a vein map on the skin to improve the time, comfort and cost of care," said Stephen P. Conlon, President, AccuVein. "We've had strong interest from a broad range of Military, Federal and State medical institutions and the GSA agreement enables greater access to this important advancement in patient care."

Weighing only 10 ounces, the AV300 uses point-and-click technology -- the healthcare professional simply presses a button and positions the device above the patient's skin to display a map on the skin of underlying veins. With a range of hands-free options, the AV300 can quickly switch between a hand-held and hands-free mode, freeing the practitioner's hands to perform the venipuncture.

Government organizations that can purchase the AccuVein AV300 from the GSA Schedule include:

  • The Department of Health and Human Services
  • Indian Health Service and the Office of Tribal Programs
  • Department of Justice
  • Federal Bureau of Prisons
  • Department of Defense
  • VA Medical Centers, Clinics and Military Hospitals

For more information and to see videos of the AccuVein AV300 in action, please visit AccuVein representatives will also be on-site at the American Association for Clinical Chemistry Annual Meeting and Clinical Lab Expo, Booth 1572, July 19-23, in Chicago, Illinois.

About AccuVein

AccuVein applies advanced technologies to important healthcare challenges. Their innovative AV300 allows practitioners to see a map on the patient's skin of the position of veins, helping caregivers locate veins while they perform the most common invasive medical procedure -- venipuncture. Built using AccuVein's expertise in medical device modernization and user-intuitive design, the AV300 is the world's first portable, non-contact vein illumination solution. With more than a dozen patents filed worldwide, AccuVein demonstrates an ongoing commitment to invest in improving patient care and patient satisfaction.

For more information on the AccuVein AV300, please visit

About GSA

GSA provides a centralized delivery system of products and services to the federal government, leveraging its enormous buying power to get the best value for taxpayers.

  • Founded in 1949, GSA manages more than one-fourth of the government's total procurement dollars and influences the management of $500 billion in federal assets, including 8,600 government-owned or leased buildings and 213,000 vehicles.
  • GSA helps preserve our past and define our future, as a steward of more than 480 historic properties, and as manager of, the official portal to federal government information and services.
  • GSA's mission to provide superior workplaces, expert technology solutions, acquisition services, purchasing and E-Gov travel solutions and management policies, at best value, allows federal agencies to focus on their core missions.

More information is available at

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Video: AccuVein Launches First Portable, Non-Contact Vein Illumination Device
2. Prometheus Launches MyCeliacID(TM), the First Do it Yourself, Saliva-Based Genetic Test Dedicated to Celiac Disease
3. Video: New Online Film Introduces Longevinex Advantage(TM) -- The First Resveratrol-Based Dietary Supplement to Address Both Cellular and Connective Tissue Aging
4. MD Now Urgent Care Centers: First in Florida to Receive UCAOA Certification in Urgent Care
5. Aegis Living Was Created To Place People First in Senior and Assisted Living Communities
6. Team Type 1 Takes First Place Finish in Race Across America
7. Nations first childrens hospital-based safety store focuses on child injury prevention
8. First Day of Summer Has Come: Enjoy the Summer Sunshine Without Putting Yourself at Risk
9. MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans
10. First Coast Medicare to Provide Case by Case Reimbursement for the Renessa(R) Treatment for Incontinence in Women
11. Cytox Raises Pre-Series A Financing From Management and Existing UK Investors, Welcomes First US Investors
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... The McHenry County law firm ... appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys Botto ... Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, Adcock testified ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new ... systems. The new app features a more intuitive SleepScore™ that rates sleep quality on ... slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to ...
(Date:11/25/2015)... ... ... Today, Mothers Against Drunk Driving (MADD) learned that the number of ... time since 2011. In 2014, there were 9,967 fatalities involving an alcohol impaired driver, ... Traffic Safety Administration (NHTSA), 32,675 people were killed in traffic crashes in 2014. Drunk ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately ... has undertaken significant expansion of its current state of the art research, development ... PharmaTech’s strategy to increase its manufacturing capacity as well as to support its ...
(Date:11/25/2015)... ... 2015 , ... Since its launch in 2012, the Regenestem ... cell therapies to patients with chronic degenerative medical conditions. Now, the U.S. Patent ... (RTM). , Organizations are required to hold a registered trademark in order to ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 25, 2015  Mindray Medical International ... MR ), a leading developer, manufacturer ... today announced that it will hold ... shareholders at the Company,s Hong Kong office (FLAT/RM ... Edward West Road, Mongkok KL, Hong Kong) ...
(Date:11/25/2015)... Pennsylvania , November 25, 2015 - ... Continuing Medical Education (CME) --> ... Continuing Medical Education (CME) --> ... Care Continuing Medical Education (CME) ... medical information products and services, will feature latest diagnostic imaging textbooks ...
(Date:11/25/2015)... LYON , Frankreich, November 25, 2015 ... hat heute bekanntgegeben, dass sie eine Lizenz für das ... Inserm, Poxel, CNRS, UCBL und ENS-Lyon innehaben, an Enyo ... 2009 von FUI AAP8 ins Leben gerufenen und von ... NATHEB-Programms wurde FXR als ein Behandlungsziel für HBV identifiziert, ...
Breaking Medicine Technology: